PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Motherwort injection combined with oxytocin is used for PPH prevention [PMID:40527062]; a systematic review and meta-analysis of RCTs indicates benefits of motherwort injection for preventing post-abortion uterine hemorrhage [PMID:35935833].
Widely used to treat menstrual disorders, including dysmenorrhea and amenorrhea [PMID:33017723, PMID:31195353].
Leonurine and stachydrine are identified as potential agents for treating cardiovascular and central nervous system diseases due to anti-inflammatory and neuroprotective activities [PMID:36940619, PMID:33300684].
Safety & adverse effects
Pregnancy & lactation
Evidence summary
PubMed sources
- 1.PMID: 36775079 (2023) — Jinfeng pills ameliorate premature ovarian insufficiency induced by cyclophosphamide in rats and correlate to modulating IL-17A/IL-6 axis and MEK/ERK signals. · Journal of ethnopharmacology
- 2.PMID: 40527062 (2025) — Motherwort synergized with oxytocin for postpartum hemorrhage prevention: Integrated clinical efficacy and mechanism exploration. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 3.PMID: 33017723 (2020) — Uncovering the pharmacological mechanism of motherwort (Leonurus japonicus Houtt.) for treating menstrual disorders: A systems pharmacology approach. · Computational biology and chemistry
- 4.PMID: 31195353 (2019) — Leonurus japonicus (Chinese motherwort), an excellent traditional medicine for obstetrical and gynecological diseases: A comprehensive overview. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
- 5.PMID: 24412548